GlycoEra
PrivateLast Round
Series B
May 27, 2025
Total Funding Raised
$179M
Momentum Score
50 /100
Company Overview
GlycoEra is a biotechnology company focused on developing innovative biologics to meet significant medical needs in inflammatory, autoimmune, and immune-oncology conditions, utilizing a proprietary platform to create first-in-class therapeutics with customized human glycans on glycoproteins.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycoEra Comps
Public and private peers based on sector, stage, and business model.
GlycoEra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2025 | ||||
| Series A Extension | Jan 8, 2024 | ||||
| Series A | Nov 5, 2021 |
Key People
Founding team and executive leadership
GlycoEra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series B |
| Roche Venture Fund | Series B |
| Sixty Degree Capital | Series B |
| MP Healthcare Venture Management | Series B |
| 5AM Ventures | Series B, Series A Extension, Series A |
| Catalio Capital Management | Series B |
| Roche Venture Fund | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Petra Duda, M.D., Ph.D. appointed as new CMO.
- May 27, 2025
Matthew Hobson of Catalio Capital Management joins the board.
GlycoEra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlycoEra's valuation, stock price, and market status.
